Translocations Involving the Short Arm of Chromosome 17 in Chronic B-Lymphoid Disorders

Total Page:16

File Type:pdf, Size:1020Kb

Translocations Involving the Short Arm of Chromosome 17 in Chronic B-Lymphoid Disorders Leukemia (1999) 13, 460–468 1999 Stockton Press All rights reserved 0887-6924/99 $12.00 http://www.stockton-press.co.uk/leu Translocations involving the short arm of chromosome 17 in chronic B-lymphoid disorders: frequent occurrence of dicentric rearrangements and possible association with adverse outcome E Callet-Bauchu1, G Salles2, S Gazzo1, C Poncet1, D Morel1, J Page`s1, B Coiffier2, P Coeur1 and P Felman1 1Laboratoire Central d’He´matologie and 2Service d’He´matologie Clinique, Centre Hospitalier Lyon Sud, France, and UPRES-JE 1879 ‘He´mopathies Lymphoı¨des Malignes’, Universite´ Claude Bernard, Pierre-Be´nite, France Unbalanced translocations involving chromosome arm 17p, came from a FISH study demonstrating TP53 deletions in 11 where the TP53 tumor suppressor gene localizes, are rarely out of 90 (12%) patients with B-CLL.10 More recently, using described in chronic lymphocytic leukemia and small lympho- cytic lymphoma (CLL/SLL), but recent use of molecular cyto- FISH analysis, we studied three CLL/SLL cases with a recurrent genetic techniques have indicated a significant incidence of t(4;17) translocation and found that the rearrangement had TP53 deletions, suggesting the involvement of chromosome retained the centromeres of both chromosomes, leading to the 17p in these disorders. By conventional karyotype, we have formation of a dicentric rearrangement and to the TP53 identified unbalanced translocations involving 17p in 14 out of monoallelic deletion.11 Those structural abnormalities of chro- 123 (11%) CLL/SLL patients with clonal abnormalities. Cases mosome 17 with loss of material from the short arm through were characterized by resistance to chemotherapy and a poor clinical outcome. The karyotypes presented a high incidence dicentric translocations have been rarely described in chronic of complex rearrangements and 17p translocations were lymphoproliferative disorders. characterized by various partners. In 10 cases a centric fusion In the present study, we focused our interest on 17p translo- was assessed by fluorescent in situ hybridization (FISH) experi- cations in patients with CLL/SLL. We identified 11 additional ments using specific centromeric probes. The incidence of cases with rearrangements involving chromosome 17p and dicentric translocations in these series is therefore signifi- various other partners. To further characterize the chromo- cantly higher than usually described, arising in up to 71% (10 out of 14 cases). In all cases, translocations led to a monosomy somal abnormalities, we investigated the cases by means of 17p and to a TP53 monoallelic deletion. The adverse clinical FISH using painting probes, centromeric probes and a specific outcome confirms that structural abnormalities involving chro- TP53 DNA probe. We also analyzed the outcome of patients mosome 17p are associated with disease progression in with tumoral cells carrying the 17p abnormalities. patients with chronic lymphoproliferative disorders. Keywords: chromosome 17; dicentric translocation; FISH; chronic B cell disorders Materials and methods Introduction Patients In B cell chronic lymphocytic leukemia and small lympho- From February 1993 to October 1997, 226 patients with cytic lymphoma (CLL/SLL), clonal chromosome abnormalities CLL/SLL were referred to our institution. Among them, 123 are identified in approximately 50% of patients.1 However, presented clonal chromosome abnormalities. In 14 cases, kar- conventional karyotype analysis has been often hampered by yotypes displayed translocations involving the short arm of the low in vitro mitotic activity of the tumoral cells.2 Recent chromosome 17. Clinical and biological data of three patients improvement in fluorescence in situ hybridization (FISH) tech- have been previously reported.11 All cases were reviewed by niques has provided an alternative approach to assess the cyto-histopathologist experts. In 11 patients (eight males and detection and the true incidence of chromosomal aberrations three females) the diagnosis of B-CLL was assessed by the in those hematological malignancies.3,4 Among them, trisomy presence of a persistent lymphocytosis greater than 5 × 109/l. 12 and structural abnormalities of chromosome bands 13q14, In three cases, the diagnosis of SLL was based on clinical and 14q32 and 11q22–23 are the most common aberrations cyto-histological findings: patients presented at diagnosis with reported and may be associated with adverse clinical fea- disseminated lymph node enlargement, hepatomegaly and tures.5–7 In addition, in SLL (including leukemic forms), a splenomegaly while the peripheral white blood counts were del(6)(q21q23) has also been documented as a frequent recur- normal. In all cases, the tumoral cells displayed co-expression rent chromosome abnormality.8 of the CD5, CD19 and CD23 antigens, an immunophenotype In most conventional banding analysis of CLL/SLL, aber- in agreement with the diagnosis of CLL/SLL. All medical rec- rations involving chromosome 17 have not been identified as ords were reviewed for treatments and outcome, and response frequent abnormalities. In the Second International Working was assessed using the revised NCI criteria.12 Party on Chromosomes in CLL (IWCCLL), which compiled the cytogenetic data from 662 patients, 22 of 649 (4%) evaluable tumors had rearrangements of chromosome 17, mostly trans- locations of 17p, where the TP53 tumor suppressor gene Chromosome studies localizes.9 Further information about involvement of 17p Conventional cytogenetic studies were performed on periph- eral blood, bone marrow or lymph nodes samples. Chromo- Correspondence: E Callet-Bauchu, Unite´ d’He´matologie Cellulaire, Laboratoire Central d’He´matologie, Centre Hospitalier Lyon Sud, some analyses were carried out on RHG-banded metaphases 69495 Pierre-Be´nite Cedex, France; Fax: 33 04 78 86 33 40 as previously described and evaluated according to the ISCN Received 29 May 1998; accepted 23 October 1998 (1995) recommendations.13 Chromosome 17 dicentric rearrangements in chronic B cell disorders E Callet-Bauchu et al 461 Metaphase and interphase FISH abnormal metaphases were in a tetraploid range (Table 1). Complex karyotypes with multiple abnormal clones were Dual-color chromosome painting: For FISH study, air- observed in 11 of the 14 patients. Cells with a normal karyo- dried slides with conventional chromosome preparations were type were identified in all cases except three (patients 2, 7 used. Hybridization experiments were performed as pre- and 12). Partial karyotypes illustrating structural rearrange- viously reported with minor modifications.11 The probes used ments involving chromosome 17 are shown in Figures 1 were a biotin-labeled chromosome 17 probe (Oncor, Gai- and 2. thersburg, MD, USA) and various digoxigenin-labeled paints By conventional cytogenetic analysis, seven patients specific for chromosomes 2, 4, 12, 13, 15, 18, 19, 20 and presented a derivative chromosome 17 resulting from a trans- 22 (Oncor). The probes cohybridized to metaphases at 37°C location involving 17p11 and 2q11 (patient 1), 13q11 (patient overnight, and slides were washed in 0.5 × SSC at 72°C for 2), 15q15 (patient 3), 18q11 (patients 4–6), and either 15q11, 5 min, followed by 1 × phosphate-buffered detergent (PBD; 20q11 or 22q11 in patient 7 for whom a jumping translo- Oncor) for 2 min at room temperature. Hybridization signals cation was identified. Moreover, in patient 3 the derivative were detected by the use of a layer of fluorescein isothiocyan- chromosome was observed in two related clones, leading to ate (FITC)-conjugated avidin antibodies (5 ␮g/ml; Vector Lab- a der(17)t(15;17) in the stemline clone and to a oratories, Burlingame, CA, USA) in combination with rhoda- der(17)t(4;17)t(15;17) in an additional deviating subclone. mine-labeled antidigoxigenin antibodies (2 ␮g/ml; Boehringer In the remaining seven patients the consistent cytogenetic Mannheim, Germany). Slides were then counterstained with abnormality resulted in loss of a chromosome 17 and the pres- DAPI (0.1 ␮g/ml) in an antifade solution, observed and photo- ence of unbalanced rearrangements involving chromosome graphed on a Zeiss epifluorescence axioskop equipped with 17, in a segment distal to 17q11 and either chromosome 12p the appropriate filter combinations using a Kodak ektachrome (patients 8 and 9), 12q (patient 10), 19q (patient 11) or 4p 400 film. (patients 12–14). In patients 8 and 9, the derivative chromo- In a few cases, a second stage hybridization using somes 12 were interpreted as der(12)t(12;17)(p12;q11). In additional paints was required. This prompted us to investi- patient 10, the derivative chromosome 12 was generated by gate the same slide repeatedly by applying various combi- two translocations, one involving the short arm, resulting from nations of biotin- or digoxigenin-labeled probes. Consecutive a translocation between band 12p13 and the segment experiments were then performed as described above. Signals 18q24 → 18 qter and the other involving the long arm, with related to probes applied in previous hybridizations were not a translocation of the segment 17q11→17 qter to band 12q15. visible using adequate labeled probes and detection systems In patient 11, the same chromosome 17 was involved in two or fluorochromes, as recently reported.14 distinct clones leading to a der(19) t(17;19)(q11;q13) in the stemline clone and to a der(2) t(2;17)(p24;q11) in an additional unrelated clone. FISH with ␣ satellite DNA probes: Dual-color hybridiz- Associated clonal abnormalities were identified in
Recommended publications
  • Chromosome 18
    Chromosome 18 Description Humans normally have 46 chromosomes in each cell, divided into 23 pairs. Two copies of chromosome 18, one copy inherited from each parent, form one of the pairs. Chromosome 18 spans about 78 million DNA building blocks (base pairs) and represents approximately 2.5 percent of the total DNA in cells. Identifying genes on each chromosome is an active area of genetic research. Because researchers use different approaches to predict the number of genes on each chromosome, the estimated number of genes varies. Chromosome 18 likely contains 200 to 300 genes that provide instructions for making proteins. These proteins perform a variety of different roles in the body. Health Conditions Related to Chromosomal Changes The following chromosomal conditions are associated with changes in the structure or number of copies of chromosome 18. Distal 18q deletion syndrome Distal 18q deletion syndrome occurs when a piece of the long (q) arm of chromosome 18 is missing. The term "distal" means that the missing piece (deletion) occurs near one end of the chromosome arm. The signs and symptoms of distal 18q deletion syndrome include delayed development and learning disabilities, short stature, weak muscle tone ( hypotonia), foot abnormalities, and a wide variety of other features. The deletion that causes distal 18q deletion syndrome can occur anywhere between a region called 18q21 and the end of the chromosome. The size of the deletion varies among affected individuals. The signs and symptoms of distal 18q deletion syndrome are thought to be related to the loss of multiple genes from this part of the long arm of chromosome 18.
    [Show full text]
  • Searching the Genomes of Inbred Mouse Strains for Incompatibilities That Reproductively Isolate Their Wild Relatives
    Journal of Heredity 2007:98(2):115–122 ª The American Genetic Association. 2007. All rights reserved. doi:10.1093/jhered/esl064 For permissions, please email: [email protected]. Advance Access publication January 5, 2007 Searching the Genomes of Inbred Mouse Strains for Incompatibilities That Reproductively Isolate Their Wild Relatives BRET A. PAYSEUR AND MICHAEL PLACE From the Laboratory of Genetics, University of Wisconsin, Madison, WI 53706. Address correspondence to the author at the address above, or e-mail: [email protected]. Abstract Identification of the genes that underlie reproductive isolation provides important insights into the process of speciation. According to the Dobzhansky–Muller model, these genes suffer disrupted interactions in hybrids due to independent di- vergence in separate populations. In hybrid populations, natural selection acts to remove the deleterious heterospecific com- binations that cause these functional disruptions. When selection is strong, this process can maintain multilocus associations, primarily between conspecific alleles, providing a signature that can be used to locate incompatibilities. We applied this logic to populations of house mice that were formed by hybridization involving two species that show partial reproductive isolation, Mus domesticus and Mus musculus. Using molecular markers likely to be informative about species ancestry, we scanned the genomes of 1) classical inbred strains and 2) recombinant inbred lines for pairs of loci that showed extreme linkage disequi- libria. By using the same set of markers, we identified a list of locus pairs that displayed similar patterns in both scans. These genomic regions may contain genes that contribute to reproductive isolation between M. domesticus and M.
    [Show full text]
  • 22Q13.3 Deletion Syndrome
    22q13.3 deletion syndrome Description 22q13.3 deletion syndrome, which is also known as Phelan-McDermid syndrome, is a disorder caused by the loss of a small piece of chromosome 22. The deletion occurs near the end of the chromosome at a location designated q13.3. The features of 22q13.3 deletion syndrome vary widely and involve many parts of the body. Characteristic signs and symptoms include developmental delay, moderate to profound intellectual disability, decreased muscle tone (hypotonia), and absent or delayed speech. Some people with this condition have autism or autistic-like behavior that affects communication and social interaction, such as poor eye contact, sensitivity to touch, and aggressive behaviors. They may also chew on non-food items such as clothing. Less frequently, people with this condition have seizures or lose skills they had already acquired (developmental regression). Individuals with 22q13.3 deletion syndrome tend to have a decreased sensitivity to pain. Many also have a reduced ability to sweat, which can lead to a greater risk of overheating and dehydration. Some people with this condition have episodes of frequent vomiting and nausea (cyclic vomiting) and backflow of stomach acids into the esophagus (gastroesophageal reflux). People with 22q13.3 deletion syndrome typically have distinctive facial features, including a long, narrow head; prominent ears; a pointed chin; droopy eyelids (ptosis); and deep-set eyes. Other physical features seen with this condition include large and fleshy hands and/or feet, a fusion of the second and third toes (syndactyly), and small or abnormal toenails. Some affected individuals have rapid (accelerated) growth.
    [Show full text]
  • Laboratory Testing for Her2 Status in Breast Cancer
    Laboratory Testing for Her2 Status in Breast Cancer Katherine Geiersbach, M.D. Assistant Professor, Department of Pathology May 28, 2015 Overview • Clinical relevance of Her2 status for treatment of breast cancer • Standard approaches for determining Her2 status in breast cancer • Current concepts and controversies in Her2 testing 2 Who gets breast cancer? • Breast cancer is one of the most common malignancies to affect women • About 1 in 8 women will be diagnosed with breast cancer at some point in her lifetime • Most cases of breast cancer are sporadic, but a small percentage (5-10%) are related to a heritable gene mutation, most commonly BRCA1 or BRCA2 • Having a first degree relative with breast cancer increases a woman’s chance of developing breast cancer • Screening mammography is recommended for older women – US Preventive Services Task Force: Every 2 years starting at age 50 – American Cancer Society, others: Every 2 years starting at age 40 How is breast cancer treated? • Surgery: excision with or without sentinel lymph node biopsy – Breast conserving: lumpectomy, partial mastectomy – Mastectomy • Chemotherapy: before and/or after surgery • Radiation • Targeted therapies – Hormone therapy: Tamoxifen, aromatase inhibitors – Her2 targeted therapy for cancers with overexpression of the gene ERBB2, commonly called Her2 or Her2/neu • Treatment is based on testing for ER, PR, and Her2 status, as well as cancer grade and stage. 4 Her2 targeted therapy • Herceptin (trastuzumab) • Others: pertuzumab (Perjeta), T-DM1 (Kadcyla), and lapatinib (Tykerb) • Recent data shows that a combination of pertuzumab, trastuzumab, and docetaxel (PTD) improved progression free survival compared to patients who had only trastuzumab and docetaxel (TD)1,2 source: http://www.perjeta.com/hcp/moa 1.
    [Show full text]
  • Chromosome Abberrations N Genetic Diseases
    Chromosomal Analysis Dr. Monisha Banerjee Professor Molecular & Human Genetics Laboratory Department of Zoology University of Lucknow Lucknow-226007 Chromosome Morphology Telomere Short arm (p) Centromere Arm Long arm (q) Telomere Metacentric Submetacentric Acrocentric Defining Chromosomal Location Arm Region Band Subband 3 2 2 1 2 2 p 1 1 5 1 4 1 3 2 1 1 2 17 q 1 1 . 2 1 1 3 1 2 2 q 3 1 3 2, 3 4 2 1 4 2 Chromosome 17 3 Nomenclature system Visualizing Metaphase Chromosomes • Patient cells are incubated and divide in tissue culture. • Phytohemagglutinin (PHA): stimulates cell division. • Colcemid: arrests cells in metaphase. • 3:1 Methanol:Acetic Acid: fixes metaphase chromosomes for staining. Visualizing Metaphase Chromosomes (Banding) • Giemsa-, reverse- or centromere-stained metaphase chromosomes G-Bands R-Bands C-Bands Karyotype • International System for Human Cytogenetic Nomenclature (ISCN) – 46, XX – normal female – 46, XY – normal male • G-banded chromosomes are identified by band pattern. Normal Female Karyotype (46, XX) (G Banding) Types of Chromosomal Aberrations Numerical Abnormalities Structural Abnormalities Aneuploidy Aneuploidy occurs when one of the chromosomes is present in an abnormal number of copies. Trisomy and monosomy are two forms of aneuploidy. Chromosome Number Abnormality Aneuploidy (48, XXXX) Chromosome Number Abnormality Trisomy 21 (47, XX, +21) Down Syndrome is Caused by Trisomy for Chromosome 21 Aneuploidy is remarkably common, causing termination of at least 25% of human conceptions. Aneuploidy is also a driving force in cancer progression (virtually all cancer cells are aneuploid). Chromosome Non-Disjunction in Meiosis Causes Aneuploidy The Frequency of Chromosome Non-Disjunction And Down Syndrome Rises Sharply with Maternal Age Chromosome Number Abnormality Trisomy 13 (47, XX, +13) Trisomy 18 (47, XY,+18) Sex Chromosome Aneuploid Conditions are Common Klinefelter syndrome Polyploidy Polyploidy occurs when all the chromosomes are present in three or more copies.
    [Show full text]
  • Dr. Fern Tsien, Dept. of Genetics, LSUHSC, NO, LA Down Syndrome
    COMMON TYPES OF CHROMOSOME ABNORMALITIES Dr. Fern Tsien, Dept. of Genetics, LSUHSC, NO, LA A. Trisomy: instead of having the normal two copies of each chromosome, an individual has three of a particular chromosome. Which chromosome is trisomic determines the type and severity of the disorder. Down syndrome or Trisomy 21, is the most common trisomy, occurring in 1 per 800 births (about 3,400) a year in the United States. It is one of the most common genetic birth defects. According to the National Down Syndrome Society, there are more than 400,000 individuals with Down syndrome in the United States. Patients with Down syndrome have three copies of their 21 chromosomes instead of the normal two. The major clinical features of Down syndrome patients include low muscle tone, small stature, an upward slant to the eyes, a single deep crease across the center of the palm, mental retardation, and physical abnormalities, including heart and intestinal defects, and increased risk of leukemia. Every person with Down syndrome is a unique individual and may possess these characteristics to different degrees. Down syndrome patients Karyotype of a male patient with trisomy 21 What are the causes of Down syndrome? • 95% of all Down syndrome patients have a trisomy due to nondisjunction before fertilization • 1-2% have a mosaic karyotype due to nondisjunction after fertilization • 3-4% are due to a translocation 1. Nondisjunction refers to the failure of chromosomes to separate during cell division in the formation of the egg, sperm, or the fetus, causing an abnormal number of chromosomes. As a result, the baby may have an extra chromosome (trisomy).
    [Show full text]
  • Impact of Fluorescence in Situ Hybridization in the Detection of Cryptic Fusion Transcript PML/RARA and a Complex T(5;15;17) in a Case of Acute Promyelocytic Leukemia
    Impact of Fluorescence in Situ Hybridization in the Detection of Cryptic Fusion Transcript PML/RARA and A Complex t(5;15;17) in a Case of Acute Promyelocytic Leukemia Gönül OGUR*,****, Turgay FEN**, Gülsan SUCAK***, Pierre HEIMANN*, Gaye CANKUÞ****, Rauf HAZNEDAR**** * Univérsité Libre de Bruxelles, Hôpital Erasme, Service Génétique Medicale, Bruxelles, BELGIUM ** Oncology Hospital, Ankara, TURKEY *** Adult Hematology Department, Faculty of Medicine, Gazi University, Ankara, TURKEY **** GEN-MED Genetic Diseases and Prenatal Diagnosis Center, Ankara, TURKEY ABSTRACT Genetic aspects of a 28 year-old female patient with typical morphological and clinical features of acute promyelocytic leukemia is presented. Pml/rara fusion transcript and a complex translocation involving chromosomes 5, 15 and 17 were detected by fluorescence in situ hybridization (FISH) tech- nique which was applied as in adjunct to conventional cytogenetics. The patient deceased soon in spite of the immediate ATRA and cytostatic therapy. Key Words: FISH, PML/RARA, Acute promyelocytic leukemia. Turk J Haematol 2000;17(4):207-212. INTRODUCTION sociated with t(15;17)(q22;q12-21). The diagnosis of APL and the detection of residual disease are Acute promyelocytic leukemia (APL) is a rara based on the presence of this translocati- distinct subtype of myeloid leukemia characterized on[1,3,4,5,6,7,15]. Rarely alternative balanced trans- by invasion of bone marrow by hypergranular le- locations have been described in subtypes of APL, ukemia cells, by specific translocations almost al- and as more cases are being evaluated, complex, ways involving chromosome 17 and by a high sen- variant translocations are increasingly recogni- sitivity of the promyelocytic blasts to retinoic acid zed[17,19,20,22, 24].
    [Show full text]
  • 12Q Deletions FTNW
    12q deletions rarechromo.org What is a 12q deletion? A deletion from chromosome 12q is a rare genetic condition in which a part of one of the body’s 46 chromosomes is missing. When material is missing from a chromosome, it is called a deletion. What are chromosomes? Chromosomes are the structures in each of the body’s cells that carry genetic information telling the body how to develop and function. They come in pairs, one from each parent, and are numbered 1 to 22 approximately from largest to smallest. Additionally there is a pair of sex chromosomes, two named X in females, and one X and another named Y in males. Each chromosome has a short (p) arm and a long (q) arm. Looking at chromosome 12 Chromosome analysis You can’t see chromosomes with the naked eye, but if you stain and magnify them many hundreds of times under a microscope, you can see that each one has a distinctive pattern of light and dark bands. In the diagram of the long arm of chromosome 12 on page 3 you can see the bands are numbered outwards starting from the point at the top of the diagram where the short and long arms meet (the centromere). Molecular techniques If you magnify chromosome 12 about 850 times, a small piece may be visibly missing. But sometimes the missing piece is so tiny that the chromosome looks normal through a microscope. The missing section can then only be found using more sensitive molecular techniques such as FISH (fluorescence in situ hybridisation, a technique that reveals the chromosomes in fluorescent colour), MLPA (multiplex ligation-dependent probe amplification) and/or array-CGH (microarrays), a technique that shows gains and losses of tiny amounts of DNA throughout all the chromosomes.
    [Show full text]
  • The Epidemiology of Sex Chromosome Abnormalities
    Received: 12 March 2020 Revised: 11 May 2020 Accepted: 11 May 2020 DOI: 10.1002/ajmg.c.31805 RESEARCH REVIEW The epidemiology of sex chromosome abnormalities Agnethe Berglund1,2,3 | Kirstine Stochholm3 | Claus Højbjerg Gravholt2,3 1Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark Abstract 2Department of Molecular Medicine, Aarhus Sex chromosome abnormalities (SCAs) are characterized by gain or loss of entire sex University Hospital, Aarhus, Denmark chromosomes or parts of sex chromosomes with the best-known syndromes being 3Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Turner syndrome, Klinefelter syndrome, 47,XXX syndrome, and 47,XYY syndrome. Denmark Since these syndromes were first described more than 60 years ago, several papers Correspondence have reported on diseases and health related problems, neurocognitive deficits, and Agnethe Berglund, Department of Clinical social challenges among affected persons. However, the generally increased comor- Genetics, Aarhus University Hospital, Aarhus, Denmark. bidity burden with specific comorbidity patterns within and across syndromes as well Email: [email protected] as early death of affected persons was not recognized until the last couple of Funding information decades, where population-based epidemiological studies were undertaken. More- Familien Hede Nielsens Fond; Novo Nordisk over, these epidemiological studies provided knowledge of an association between Fonden, Grant/Award Numbers: NNF13OC0003234, NNF15OC0016474 SCAs and a negatively reduced socioeconomic status in terms of education, income, retirement, cohabitation with a partner and parenthood. This review is on the aspects of epidemiology in Turner, Klinefelter, 47,XXX and 47,XYY syndrome. KEYWORDS 47,XXX syndrome, 47,XYY syndrome, epidemiology, Klinefelter syndrome, Turner syndrome 1 | INTRODUCTION 100 participants, and many with much fewer participants.
    [Show full text]
  • Investigation of Differentially Expressed Genes in Nasopharyngeal Carcinoma by Integrated Bioinformatics Analysis
    916 ONCOLOGY LETTERS 18: 916-926, 2019 Investigation of differentially expressed genes in nasopharyngeal carcinoma by integrated bioinformatics analysis ZhENNING ZOU1*, SIYUAN GAN1*, ShUGUANG LIU2, RUjIA LI1 and jIAN hUANG1 1Department of Pathology, Guangdong Medical University, Zhanjiang, Guangdong 524023; 2Department of Pathology, The Eighth Affiliated hospital of Sun Yat‑sen University, Shenzhen, Guangdong 518033, P.R. China Received October 9, 2018; Accepted April 10, 2019 DOI: 10.3892/ol.2019.10382 Abstract. Nasopharyngeal carcinoma (NPC) is a common topoisomerase 2α and TPX2 microtubule nucleation factor), malignancy of the head and neck. The aim of the present study 8 modules, and 14 TFs were identified. Modules analysis was to conduct an integrated bioinformatics analysis of differ- revealed that cyclin-dependent kinase 1 and exportin 1 were entially expressed genes (DEGs) and to explore the molecular involved in the pathway of Epstein‑Barr virus infection. In mechanisms of NPC. Two profiling datasets, GSE12452 and summary, the hub genes, key modules and TFs identified in GSE34573, were downloaded from the Gene Expression this study may promote our understanding of the pathogenesis Omnibus database and included 44 NPC specimens and of NPC and require further in-depth investigation. 13 normal nasopharyngeal tissues. R software was used to identify the DEGs between NPC and normal nasopharyngeal Introduction tissues. Distributions of DEGs in chromosomes were explored based on the annotation file and the CYTOBAND database Nasopharyngeal carcinoma (NPC) is a common malignancy of DAVID. Gene ontology (GO) and Kyoto Encyclopedia of occurring in the head and neck. It is prevalent in the eastern Genes and Genomes (KEGG) pathway enrichment analysis and southeastern parts of Asia, especially in southern China, were applied.
    [Show full text]
  • Duplications of 17P FTNW
    Duplications of 17p rarechromo.org 17p duplications A 17p duplication means that the cells of the body have a small but variable amount of extra genetic material from one of their 46 chromosomes – chromosome 17. For healthy development, chromosomes should contain just the right amount of genetic material (DNA) – not too much and not too little. Like most other chromosome disorders, having an extra part of chromosome 17 may increase the risk of birth defects, developmental delay and learning (intellectual) disability. However, the problems vary and depend on what and how much genetic material is duplicated. Background on Chromosomes Chromosomes are structures which contain our DNA and are found in almost every cell of the body. Every chromosome contains thousands of genes which may be thought of as individual instruction booklets (or recipes) that contain all the genetic information telling the body how to develop, grow and function. Chromosomes (and genes) usually come in pairs with one member of each chromosome pair being inherited from each parent. Most cells of the human body have a total of 46 (23 pairs of) chromosomes. The egg and the sperm cells, however have 23 unpaired chromosomes, so that when the egg and sperm join together at conception, the chromosomes pair up and the number is restored to 46. Of these 46 chromosomes, two are the sex chromosomes that determine gender. Females have two X chromosomes and males have one X chromosome and one Y chromosome. The remaining 44 chromosomes are grouped in 22 pairs, numbered 1 to 22 approximately from the largest to the smallest.
    [Show full text]
  • Rapid Molecular Assays to Study Human Centromere Genomics
    Downloaded from genome.cshlp.org on September 26, 2021 - Published by Cold Spring Harbor Laboratory Press Method Rapid molecular assays to study human centromere genomics Rafael Contreras-Galindo,1 Sabrina Fischer,1,2 Anjan K. Saha,1,3,4 John D. Lundy,1 Patrick W. Cervantes,1 Mohamad Mourad,1 Claire Wang,1 Brian Qian,1 Manhong Dai,5 Fan Meng,5,6 Arul Chinnaiyan,7,8 Gilbert S. Omenn,1,9,10 Mark H. Kaplan,1 and David M. Markovitz1,4,11,12 1Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109, USA; 2Laboratory of Molecular Virology, Centro de Investigaciones Nucleares, Facultad de Ciencias, Universidad de la República, Montevideo, Uruguay 11400; 3Medical Scientist Training Program, University of Michigan, Ann Arbor, Michigan 48109, USA; 4Program in Cancer Biology, University of Michigan, Ann Arbor, Michigan 48109, USA; 5Molecular and Behavioral Neuroscience Institute, University of Michigan, Ann Arbor, Michigan 48109, USA; 6Department of Psychiatry, University of Michigan, Ann Arbor, Michigan 48109, USA; 7Michigan Center for Translational Pathology and Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA; 8Howard Hughes Medical Institute, Chevy Chase, Maryland 20815, USA; 9Department of Human Genetics, 10Departments of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan 48109, USA; 11Program in Immunology, University of Michigan, Ann Arbor, Michigan 48109, USA; 12Program in Cellular and Molecular Biology, University of Michigan, Ann Arbor, Michigan 48109, USA The centromere is the structural unit responsible for the faithful segregation of chromosomes. Although regulation of cen- tromeric function by epigenetic factors has been well-studied, the contributions of the underlying DNA sequences have been much less well defined, and existing methodologies for studying centromere genomics in biology are laborious.
    [Show full text]